(PTCT) PTC Therapeutics - Performance 55.9% in 12m

PTCT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating 2.34%
#32 in Peer-Group
Rel. Strength 86.90%
#974 in Stock-Universe
Total Return 12m 55.89%
#22 in Peer-Group
Total Return 5y -10.14%
#37 in Peer-Group
P/E Value
P/E Trailing 7.71
P/E Forward 6.26
High / Low USD
52 Week High 57.17 USD
52 Week Low 30.39 USD
Sentiment Value
VRO Trend Strength +-100 19.63
Buy/Sell Signal +-5 -0.75
Support / Resistance Levels
Support 48.3, 35.4
Resistance 55.3
12m Total Return: PTCT (55.9%) vs XBI (-10.7%)
Total Return of PTC Therapeutics versus its related sector ETF XBI
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (PTCT) PTC Therapeutics - Performance 55.9% in 12m

Top Performer in Biotechnology

Short Term Performance

Symbol 1w 1m 3m
PTCT -2.08% -0.49% 4.27%
RGC -36.4% -25.8% 1,814%
VOR 350% 511% 131%
TNGX 1.49% 114% 325%

Long Term Performance

Symbol 6m 12m 5y
PTCT 5.91% 55.9% -10.1%
RGC 0.0% 0.0% 5,184%
DRUG -35.3% 2,431% -1.56%
RGLS 423% 329% -1.09%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
GILD NASDAQ
Gilead Sciences
3.32% 68% 77.8% 22.7 13.6 0.23 28.3% -3.71%
UTHR NASDAQ
United Therapeutics
-10.6% -8.81% 144% 11.3 10.5 1.43 74.6% 16.1%
AMGN NASDAQ
Amgen
0.71% -3.57% 32.5% 25.4 13.4 0.93 0.60% 41%
BIM PA
Biomerieux
-0.36% 31.7% -6.18% 33.1 25.8 1.55 -38.5% -25.1%
NBIX NASDAQ
Neurocrine Biosciences
2.76% -8.64% 0.27% 43 24.8 0.27 18.7% -34.3%
KMDA NASDAQ
Kamada
12.5% 65.3% -5.65% 25.5 22.8 0.91 48.1% 3.93%
PTCT NASDAQ
PTC Therapeutics
-0.49% 55.9% -10.1% 7.71 6.26 0.81 - 68%
ERF PA
Eurofins Scientific SE
3.44% 35.3% 14.7% 28.9 15.4 0.64 -62.1% -19.3%

Performance Comparison: PTCT vs XBI vs S&P 500

XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PTCT
Total Return (including Dividends) PTCT XBI S&P 500
1 Month -0.49% 2.27% 4.52%
3 Months 4.27% 6.30% 10.43%
12 Months 55.89% -10.68% 14.67%
5 Years -10.14% -26.13% 109.23%

Trend Score (consistency of price movement) PTCT XBI S&P 500
1 Month -58.8% 5.5% 79.1%
3 Months 59.5% 74.3% 94.2%
12 Months 82% -84.7% 44.4%
5 Years -31.8% -52.6% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XBI vs. S&P 500
1 Month %th55.00 -2.70% -4.79%
3 Month %th50.50 -1.91% -5.58%
12 Month %th90.00 74.52% 35.94%
5 Years %th82.00 21.65% -57.05%

FAQs

Does PTC Therapeutics (PTCT) outperform the market?

Yes, over the last 12 months PTCT made 55.89%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%. Over the last 3 months PTCT made 4.27%, while XBI made 6.30%.

Performance Comparison PTCT vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

PTCT vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -3.9% -5% -0.4% 41%
US NASDAQ 100 QQQ -3.4% -5.2% -1.6% 42%
German DAX 40 DAX -2.2% 0.6% -11.8% 27%
Shanghai Shenzhen CSI 300 CSI 300 -2.9% -4.7% -1.3% 38%
Hongkong Hang Seng HSI -2.1% -6.6% -18.1% 20%
India NIFTY 50 INDA -4% -2.9% 1.3% 56%
Brasil Bovespa EWZ -5% -8% -23.2% 43%

PTCT vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -4.5% -6.5% -5.5% 28%
Consumer Discretionary XLY -3.3% -2.6% 6.9% 36%
Consumer Staples XLP -2.9% -0.1% 0% 45%
Energy XLE -2.7% -4.8% 5.7% 59%
Financial XLF -4.2% -4.1% -4.1% 26%
Health Care XLV -4.3% -4% 5.7% 60%
Industrial XLI -4.1% -4.6% -7.5% 31%
Materials XLB -4.8% -4.7% -3.4% 50%
Real Estate XLRE -0.8% -1.2% 0.8% 43%
Technology XLK -3.6% -8.4% -2.7% 45%
Utilities XLU -2.5% -0.9% -3% 31%
Aerospace & Defense XAR -4.5% -7.7% -18.8% 7%
Biotech XBI -1.2% -2.8% 15.1% 67%
Homebuilder XHB -6.4% -11% 6.2% 51%
Retail XRT -4.9% -5% 5.4% 47%

PTCT vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -3.4% -6.79% 9.81% 65%
Natural Gas UNG 4.9% 9.9% 17.1% 65%
Gold GLD -2.5% 0.8% -19.4% 13%
Silver SLV -2.5% -4.1% -15.6% 34%
Copper CPER -5% -4.4% -18.8% 41%

PTCT vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -2.9% -4% 3.5% 54%
iShares High Yield Corp. Bond HYG -2.1% -1.7% 1.8% 46%